A Phase III, Multi-Center, Randomized, Double-Masked, Sham Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (OAKS)
Clinical Trials
Scleral Lenses for Dry Eye
Scleral Contact Lens Reduction of Cytokines in Dry Eye Patients
YOSEMITE/RHONE-X
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients with Diabetic Macular Edema (YOSEMITE)
ARIS
Age-Related Macular Degeneration Ryan Initiative Study (ARIS)
AMBLYOPIA TREATMENT STUDY (ATS20)
Binocular Dig Rush Game Treatment for Amblyopia
AREDS2
Age-Related Eye Disease Study 2 (AREDS2) 10-Year Follow-On Study
Zoster Eye Disease Study (ZEDS)
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Suppressive Valacyclovir for One Year in Immunocompetent Study Participants with an Episode of Dendriform Epithelial Keratitis, Stromal Keratitis, Endothelial Keratitis, and/or Iritis Due to Herpes Zoster Ophthalmicus (HZO) in the Year Prior to Enrollment (ZEDS)
CHROMA
A Phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration.
INTERMITTENT EXOTROPIA STUDY (IXT1)
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia